Status:
UNKNOWN
Metastatic Colorectal Cancer Liver Metastases Outcomes After Resin 90Y Microsphere Radioembolization in the USA Evaluation Project
Lead Sponsor:
Andrew Kennedy
Collaborating Sponsors:
Sirtex Medical
Conditions:
Colorectal Cancer
Liver Metastases
Eligibility:
All Genders
18+ years
Brief Summary
Investigator initiated multi-institutional retrospective review of clinical and radiographic outcomes after 90Y resin microsphere radioembolization for metastatic colorectal liver metastases in the US...
Detailed Description
Investigator initiated multi-institutional retrospective review of clinical and radiographic outcomes after 90Y resin microsphere radioembolization for metastatic colorectal liver metastases in the US...
Eligibility Criteria
Inclusion
- Patients who received 90Y resin microsphere radioembolization for metastatic colorectal cancer with liver metastases between November 2010 and March 2011 in the USA. Patients must have at least 12 weeks of follow up.
Exclusion
- Patients who received glass 90Y microsphere radioembolization for metastatic colorectal liver metastases.
Key Trial Info
Start Date :
December 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT01815879
Start Date
December 1 2012
Last Update
March 21 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Contact Sarah Cannon
Nashville, Tennessee, United States, 37203